Molecular genetic, host-derived and clinical determinants of long-term survival in glioblastoma: First results from the ETERNITY study (EORTC 1419).

Michael Weller, Guido Reifenberger, Emilie Le Rhun, Jennifer Leigh Clarke, Riccardo Soffietti, Antje Wick, Olivier L. Chinot, Francois Ducray, Peter Hau, Kerrie Leanne McDonald, Christine Marosi, Oliver Schnell, Andreas Felix Hottinger, Jaap C. Reijneveld, Giuseppe Lombardi, Patrick Y. Wen, Martin Klein, Thierry Gorlia, Joerg Felsberg, Caroline Hertler

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
JournalJournal of Clinical Oncology
Volume37
Issue number15
Publication statusPublished - 20 May 2019

Cite this

Weller, M., Reifenberger, G., Le Rhun, E., Clarke, J. L., Soffietti, R., Wick, A., ... Hertler, C. (2019). Molecular genetic, host-derived and clinical determinants of long-term survival in glioblastoma: First results from the ETERNITY study (EORTC 1419). Journal of Clinical Oncology, 37(15).